‹ ›
MYP_115570
← PREVIOUS NEXT → BACK
Basic Information
Ple-AB
Antimicrobial
Standard
36 amino acids
C175H254N48O47S7
Standard
Sequence
GFGCPWDEMQCHNHCKSIKGYKGGYCAKGGFVCKCY
Physicochemical Analysis
4006.64 Da
8.62
2.87
2.47
0.0798
-0.47
0.36
0.03
18.42
21.67
0.1667
9970.00
10345.00
The radar chart summarizes major physicochemical dimensions for quick comparison, while exact numerical values remain listed on the left.
Residue Composition
Amino Acid Composition
Chemical Descriptors
1517.98
-14.55
58.0
59.0
129.0
277.0
10.0
37.0
Structural Visualization
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber in the current view mode. Use the buttons to zoom.
2D CHEMICAL STRUCTURE
Drag to move
Drag to move. Use the buttons to zoom.
Experimental Records
RECORD: Rec_0065109 VERIFIED: YES
Provenance & Taxonomy
synthetic construct based on Plectasin deletion variant [Synthetic]
Plectasin
32630
Structure & Mods
synthetic linear peptide [Linear]
canonical L-amino-acid peptide [L]
Bio-Activity Profile
Antimicrobial Antibacterial
Pseudomonas aeruginosa CICC 21630
>128 μg/mL
MIC
PaperPlectasin: from evolution to truncation, expression, and better druggability. PMID38188573 Evidence URLhttps://pubmed.ncbi.nlm.nih.gov/38188573/
RECORD: Rec_0145784 VERIFIED: YES
Provenance & Taxonomy
synthetic construct based on Plectasin deletion variant [Synthetic]
Plectasin
32630
Structure & Mods
synthetic linear peptide [Linear]
canonical L-amino-acid peptide [L]
Bio-Activity Profile
Antimicrobial Antibacterial
Shigella CMCC392
>128 μg/mL
MIC
PaperPlectasin: from evolution to truncation, expression, and better druggability. PMID38188573 Evidence URLhttps://pubmed.ncbi.nlm.nih.gov/38188573/
RECORD: Rec_0162115 VERIFIED: YES
Provenance & Taxonomy
synthetic construct based on Plectasin deletion variant [Synthetic]
Plectasin
32630
Structure & Mods
synthetic linear peptide [Linear]
canonical L-amino-acid peptide [L]
Bio-Activity Profile
Antimicrobial Antibacterial
Streptococcus agalactiae ATCC 13813 or CAU-FRI-2022-01 or CAU-FRI-2022-02
2-4 μg/mL
MIC
PaperPlectasin: from evolution to truncation, expression, and better druggability. PMID38188573 Evidence URLhttps://pubmed.ncbi.nlm.nih.gov/38188573/
RECORD: Rec_0171060 VERIFIED: YES
Provenance & Taxonomy
synthetic construct based on Plectasin deletion variant [Synthetic]
Plectasin
32630
Structure & Mods
synthetic linear peptide [Linear]
canonical L-amino-acid peptide [L]
Bio-Activity Profile
Antimicrobial Antibacterial
Staphylococcus aureus ATCC 43300 or ATCC 25923 or CVCC 546 or E48
4-16 μg/mL
MIC
PaperPlectasin: from evolution to truncation, expression, and better druggability. PMID38188573 Evidence URLhttps://pubmed.ncbi.nlm.nih.gov/38188573/
RECORD: Rec_0206142 VERIFIED: YES
Provenance & Taxonomy
synthetic construct based on Plectasin deletion variant [Synthetic]
Plectasin
32630
Structure & Mods
synthetic linear peptide [Linear]
canonical L-amino-acid peptide [L]
Bio-Activity Profile
Antimicrobial Antibacterial
Salmonella Enteritidis CVCC 3377
>128 μg/mL
MIC
PaperPlectasin: from evolution to truncation, expression, and better druggability. PMID38188573 Evidence URLhttps://pubmed.ncbi.nlm.nih.gov/38188573/
1 2 NEXT LAST
Showing 5 records · Page 1 of 2